A Vicious Cycle of Osteosarcopeniain Inflammatory Bowel Diseases-Aetiology, Clinical Implications and Therapeutic Perspectives

Nutrients. 2021 Jan 20;13(2):293. doi: 10.3390/nu13020293.

Abstract

Sarcopenia is a disorder characterized by a loss of muscle mass which leads to the reduction of muscle strength and a decrease in the quality and quantity of muscle. It was previously thought that sarcopenia was specific to ageing. However, sarcopenia may affect patients suffering from chronic diseases throughout their entire lives. A decreased mass of muscle and bone is common among patients with inflammatory bowel disease (IBD). Since sarcopenia and osteoporosis are closely linked, they should be diagnosed as mutual consequences of IBD. Additionally, multidirectional treatment of sarcopenia and osteoporosis including nutrition, physical activity, and pharmacotherapy should include both disorders, referred to as osteosarcopenia.

Keywords: Crohn’s disease; IBD; low muscle mass; low muscle strength; malnutrition; nutritional therapy; sarcopenia; ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Calcifediol / blood
  • Diet
  • Dietary Proteins / administration & dosage
  • Dietary Supplements
  • Exercise
  • Fatty Acids, Omega-3 / administration & dosage
  • Female
  • Humans
  • Inflammatory Bowel Diseases / complications*
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / physiopathology
  • Male
  • Malnutrition / physiopathology
  • Nutrition Therapy
  • Osteoporosis* / drug therapy
  • Osteoporosis* / etiology
  • Osteoporosis* / therapy
  • Sarcopenia* / drug therapy
  • Sarcopenia* / etiology
  • Sarcopenia* / therapy
  • Vitamin D Deficiency / etiology

Substances

  • Dietary Proteins
  • Fatty Acids, Omega-3
  • Calcifediol